Bepranemab
Modify Date: 2024-01-02 17:44:31
Bepranemab structure
|
Common Name | Bepranemab | ||
|---|---|---|---|---|
| CAS Number | 2244960-75-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BepranemabBepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research[1]. |
| Name | Bepranemab |
|---|
| Description | Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |